US Stock MarketDetailed Quotes

Catalyst Pharmaceuticals (CPRX)

Watchlist
  • 31.140
  • -0.010-0.03%
Close May 12 16:00 ET
  • 31.120
  • -0.020-0.06%
Post 20:01 ET
3.81BMarket Cap18.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Catalyst Pharmaceuticals (CPRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
5.63%149.39M
19.78%588.99M
7.61%152.61M
15.31%148.39M
19.44%146.56M
43.56%141.42M
23.49%491.73M
28.26%141.82M
25.33%128.7M
23.23%122.71M
Operating revenue
5.63%149.39M
19.78%588.99M
7.61%152.61M
15.31%148.39M
19.44%146.56M
43.56%141.42M
23.49%491.73M
28.26%141.82M
25.33%128.7M
23.23%122.71M
Cost of revenue
-19.18%14.48M
26.74%87.25M
20.47%26.07M
17.52%22.65M
33.81%20.61M
43.06%17.91M
32.48%68.85M
36.90%21.64M
36.07%19.28M
27.90%15.41M
Gross profit
9.23%134.92M
18.64%501.74M
5.29%126.54M
14.92%125.74M
17.37%125.95M
43.63%123.51M
22.14%422.89M
26.82%120.18M
23.61%109.42M
22.58%107.31M
Operating expense
2.56%61.68M
7.11%243.96M
12.84%64.69M
1.64%59.47M
12.42%59.65M
2.17%60.14M
-12.20%227.77M
8.04%57.33M
-53.46%58.51M
29.93%53.06M
Selling and administrative expenses
5.13%49.32M
9.01%193.75M
20.88%53.42M
3.47%47.47M
12.81%45.95M
-0.06%46.91M
32.93%177.74M
5.13%44.19M
36.71%45.88M
43.44%40.73M
-Selling and marketing expense
-0.80%29.66M
9.79%122.24M
9.54%33.6M
4.65%30.46M
7.76%28.28M
18.09%29.9M
28.44%111.34M
6.01%30.67M
34.24%29.11M
43.33%26.25M
-General and administrative expense
15.57%19.66M
7.70%71.51M
46.61%19.82M
1.42%17.01M
21.97%17.67M
-21.31%17.01M
41.20%66.4M
3.18%13.52M
41.22%16.78M
43.62%14.48M
Research and development costs
-31.54%2.66M
0.48%12.71M
-52.42%1.81M
-19.09%2.66M
46.00%4.36M
50.60%3.89M
-86.42%12.65M
92.60%3.8M
-96.07%3.28M
-24.51%2.99M
Depreciation amortization depletion
3.83%9.7M
0.32%37.5M
1.29%9.47M
-0.01%9.34M
0.00%9.34M
0.01%9.35M
14.78%37.38M
3.15%9.34M
10.11%9.35M
10.08%9.34M
-Depreciation and amortization
3.83%9.7M
0.32%37.5M
1.29%9.47M
-0.01%9.34M
0.00%9.34M
0.01%9.35M
14.78%37.38M
3.15%9.34M
10.11%9.35M
10.08%9.34M
Operating profit
15.57%73.23M
32.11%257.78M
-1.59%61.85M
30.17%66.27M
22.22%66.3M
133.60%63.37M
124.77%195.12M
50.73%62.84M
236.90%50.91M
16.16%54.25M
Net non-operating interest income expense
18.43%6.25M
54.16%24.77M
44.84%6.69M
51.14%6.86M
56.34%5.95M
69.78%5.28M
243.61%16.06M
224.39%4.62M
1,812.08%4.54M
109.82%3.8M
Non-operating interest income
18.43%6.25M
----
----
51.14%6.86M
56.34%5.95M
69.78%5.28M
----
----
--4.54M
--3.8M
Total other finance cost
----
-54.16%-24.77M
----
----
----
----
-243.61%-16.06M
-224.39%-4.62M
-1,812.08%-4.54M
-109.82%-3.8M
Other net income (expense)
79.65%4.75M
-80.85%972K
-49.88%3.37M
-218.76%-2.09M
-30.50%-2.95M
331.12%2.64M
-34.08%5.08M
-18.69%6.72M
409.68%1.76M
-2.26M
Gain on sale of security
79.65%4.75M
-80.85%972K
-49.88%3.37M
-218.76%-2.09M
-30.50%-2.95M
331.12%2.64M
67.82%5.08M
87.14%6.72M
409.68%1.76M
---2.26M
Income before tax
18.16%84.23M
31.10%283.52M
-3.07%71.9M
24.18%71.04M
24.21%69.29M
145.06%71.29M
128.82%216.26M
58.82%74.18M
250.46%57.21M
15.00%55.79M
Income tax
40.87%20.5M
32.11%69.19M
5.25%19.2M
37.02%18.25M
14.61%17.19M
150.24%14.55M
126.72%52.37M
53.80%18.25M
283.56%13.32M
39.48%14.99M
Net income
12.33%63.73M
30.78%214.33M
-5.79%52.7M
20.28%52.78M
27.73%52.11M
143.77%56.74M
129.50%163.89M
60.53%55.94M
242.65%43.88M
8.03%40.79M
Net income continuous Operations
12.33%63.73M
30.78%214.33M
-5.79%52.7M
20.28%52.78M
27.73%52.11M
143.77%56.74M
129.50%163.89M
60.53%55.94M
242.65%43.88M
8.03%40.79M
Minority interest income
Net income attributable to the parent company
12.33%63.73M
30.78%214.33M
-5.79%52.7M
20.28%52.78M
27.73%52.11M
143.77%56.74M
129.50%163.89M
60.53%55.94M
242.65%43.88M
8.03%40.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
12.33%63.73M
30.78%214.33M
-5.79%52.7M
20.28%52.78M
27.73%52.11M
143.77%56.74M
129.50%163.89M
60.53%55.94M
242.65%43.88M
8.03%40.79M
Basic earnings per share
10.64%0.52
26.81%1.75
-8.51%0.43
16.22%0.43
22.86%0.43
135.00%0.47
105.97%1.38
42.42%0.47
227.59%0.37
-2.78%0.35
Diluted earnings per share
11.11%0.5
28.24%1.68
-6.82%0.41
20.00%0.42
24.24%0.41
136.84%0.45
107.94%1.31
41.94%0.44
220.69%0.35
0.00%0.33
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 5.63%149.39M19.78%588.99M7.61%152.61M15.31%148.39M19.44%146.56M43.56%141.42M23.49%491.73M28.26%141.82M25.33%128.7M23.23%122.71M
Operating revenue 5.63%149.39M19.78%588.99M7.61%152.61M15.31%148.39M19.44%146.56M43.56%141.42M23.49%491.73M28.26%141.82M25.33%128.7M23.23%122.71M
Cost of revenue -19.18%14.48M26.74%87.25M20.47%26.07M17.52%22.65M33.81%20.61M43.06%17.91M32.48%68.85M36.90%21.64M36.07%19.28M27.90%15.41M
Gross profit 9.23%134.92M18.64%501.74M5.29%126.54M14.92%125.74M17.37%125.95M43.63%123.51M22.14%422.89M26.82%120.18M23.61%109.42M22.58%107.31M
Operating expense 2.56%61.68M7.11%243.96M12.84%64.69M1.64%59.47M12.42%59.65M2.17%60.14M-12.20%227.77M8.04%57.33M-53.46%58.51M29.93%53.06M
Selling and administrative expenses 5.13%49.32M9.01%193.75M20.88%53.42M3.47%47.47M12.81%45.95M-0.06%46.91M32.93%177.74M5.13%44.19M36.71%45.88M43.44%40.73M
-Selling and marketing expense -0.80%29.66M9.79%122.24M9.54%33.6M4.65%30.46M7.76%28.28M18.09%29.9M28.44%111.34M6.01%30.67M34.24%29.11M43.33%26.25M
-General and administrative expense 15.57%19.66M7.70%71.51M46.61%19.82M1.42%17.01M21.97%17.67M-21.31%17.01M41.20%66.4M3.18%13.52M41.22%16.78M43.62%14.48M
Research and development costs -31.54%2.66M0.48%12.71M-52.42%1.81M-19.09%2.66M46.00%4.36M50.60%3.89M-86.42%12.65M92.60%3.8M-96.07%3.28M-24.51%2.99M
Depreciation amortization depletion 3.83%9.7M0.32%37.5M1.29%9.47M-0.01%9.34M0.00%9.34M0.01%9.35M14.78%37.38M3.15%9.34M10.11%9.35M10.08%9.34M
-Depreciation and amortization 3.83%9.7M0.32%37.5M1.29%9.47M-0.01%9.34M0.00%9.34M0.01%9.35M14.78%37.38M3.15%9.34M10.11%9.35M10.08%9.34M
Operating profit 15.57%73.23M32.11%257.78M-1.59%61.85M30.17%66.27M22.22%66.3M133.60%63.37M124.77%195.12M50.73%62.84M236.90%50.91M16.16%54.25M
Net non-operating interest income expense 18.43%6.25M54.16%24.77M44.84%6.69M51.14%6.86M56.34%5.95M69.78%5.28M243.61%16.06M224.39%4.62M1,812.08%4.54M109.82%3.8M
Non-operating interest income 18.43%6.25M--------51.14%6.86M56.34%5.95M69.78%5.28M----------4.54M--3.8M
Total other finance cost -----54.16%-24.77M-----------------243.61%-16.06M-224.39%-4.62M-1,812.08%-4.54M-109.82%-3.8M
Other net income (expense) 79.65%4.75M-80.85%972K-49.88%3.37M-218.76%-2.09M-30.50%-2.95M331.12%2.64M-34.08%5.08M-18.69%6.72M409.68%1.76M-2.26M
Gain on sale of security 79.65%4.75M-80.85%972K-49.88%3.37M-218.76%-2.09M-30.50%-2.95M331.12%2.64M67.82%5.08M87.14%6.72M409.68%1.76M---2.26M
Income before tax 18.16%84.23M31.10%283.52M-3.07%71.9M24.18%71.04M24.21%69.29M145.06%71.29M128.82%216.26M58.82%74.18M250.46%57.21M15.00%55.79M
Income tax 40.87%20.5M32.11%69.19M5.25%19.2M37.02%18.25M14.61%17.19M150.24%14.55M126.72%52.37M53.80%18.25M283.56%13.32M39.48%14.99M
Net income 12.33%63.73M30.78%214.33M-5.79%52.7M20.28%52.78M27.73%52.11M143.77%56.74M129.50%163.89M60.53%55.94M242.65%43.88M8.03%40.79M
Net income continuous Operations 12.33%63.73M30.78%214.33M-5.79%52.7M20.28%52.78M27.73%52.11M143.77%56.74M129.50%163.89M60.53%55.94M242.65%43.88M8.03%40.79M
Minority interest income
Net income attributable to the parent company 12.33%63.73M30.78%214.33M-5.79%52.7M20.28%52.78M27.73%52.11M143.77%56.74M129.50%163.89M60.53%55.94M242.65%43.88M8.03%40.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 12.33%63.73M30.78%214.33M-5.79%52.7M20.28%52.78M27.73%52.11M143.77%56.74M129.50%163.89M60.53%55.94M242.65%43.88M8.03%40.79M
Basic earnings per share 10.64%0.5226.81%1.75-8.51%0.4316.22%0.4322.86%0.43135.00%0.47105.97%1.3842.42%0.47227.59%0.37-2.78%0.35
Diluted earnings per share 11.11%0.528.24%1.68-6.82%0.4120.00%0.4224.24%0.41136.84%0.45107.94%1.3141.94%0.44220.69%0.350.00%0.33
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +24.74%
Sample Name
Sample Code
 +22.84%
Sample Name
Sample Code
 +19.74%
4
United States Oil Fund LP
USO
+16.51%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+14.47%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.63%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +6.10%
4
Li Auto
LI
+5.40%
5
Vipshop
VIPS
+3.19%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting an immediate response from Iran: no one Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -